+39 02 610346.1 - info@newron.com

Latest press releases

  • 29Oct
    Newron Initiates Outreach on First Global Rett Syndrome Burden of Illness Survey in Collaboration with the Rett Community

  • 20Sep
    Newron Pharmaceuticals: Commercialization partner Meiji Seika together with Eisai announce the approval of safinamide for Parkinson’s disease in Japan

  • 12Sep
    Newron reports half-year 2019 results


  • 10Jul
    Newron’s commercialization partner Zambon and Valeo Pharma announce the launch of Onstryv® (safinamide) for Parkinson’s disease in Canada


  • 28Jun
    Newron Receives First Tranche from Financing Agreement with European Investment Bank (EIB)


  • 27Jun
    Newron Pharmaceuticals now also listed on the primary market of the Düsseldorf Stock Exchange and on XETRA


View All

Newron share price


  • 26Nov
    German Equity Forum 2019

    November, 25-27, 2019 -Sheraton Frankfurt Airport Hotel & Conference Center, Frankfurt, Germany

  • 20Nov
    10th Annual Jefferies 2019 London Healthcare Conference

    November 20-21, 2019 - the Waldorf Hilton, London, UK

  • 18Sep
    Investora Zürich 2019

    September 18-19, 2019 - Samsung Hall, Dübendorf, Switzerland

View Event Calendar